Siga Technologies (SIGA) Net Income towards Common Stockholders Growth (3y) (2013 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) Net Income towards Common Stockholders Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 2.47% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 39.28% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 12.12% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -28.09% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -36.57% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 42.23% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 8.71% |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -29.91% |
| Jun 30, 2025 | 161.33% |
| Mar 31, 2025 | -0.86% |
| Dec 31, 2024 | -14.57% |
| Sep 30, 2024 | 34.47% |
| Jun 30, 2024 | 107.57% |
| Mar 31, 2024 | 99.48% |
| Dec 31, 2023 | 53.03% |
| Sep 30, 2023 | -26.33% |
| Jun 30, 2023 | -28.82% |
| Mar 31, 2023 | 53.10% |
| Dec 31, 2022 | 44.77% |
| Sep 30, 2022 | 157.64% |
| Jun 30, 2022 | 36.09% |
| Mar 31, 2022 | 37.88% |
| Dec 31, 2021 | 11.89% |
| Sep 30, 2021 | -26.16% |
| Jun 30, 2021 | 66.76% |
| Mar 31, 2021 | 46.93% |
| Dec 31, 2020 | 58.17% |